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Abstract
Background: Identifying the genotypes underlying human disease phenotypes is a fundamental step in human
genetics and medicine. High-throughput genomic technologies provide thousands of genetic variants per individual.
The causal genes of a specific phenotype are usually expected to be functionally close to each other. According to this
hypothesis, candidate genes are picked from high-throughput data on the basis of their biological proximity to core
genes— genes already known to be responsible for the phenotype. There is currently no effective gene-centric online
interface for this purpose.
Results: We describe here the human gene connectome server (HGCS), a powerful, easy-to-use interactive online tool
enabling researchers to prioritize any list of genes according to their biological proximity to core genes associated with the
phenotype of interest. We also make available an updated and extended version for all human gene-specific connectomes.
The HGCS is freely available to noncommercial users from: http://hgc.rockefeller.edu/.
Conclusions: The HGCS should help investigators from diverse fields to identify new disease-causing candidate genes
more effectively, via a user-friendly online interface.
Background
The identification of causal links between human genotypes
and disease phenotypes is a key challenge in human gen-
omics, genetics and medicine. The high-throughput data
generated by next-generation sequencing (NGS), micro-
array studies, genome-wide association studies (GWAS)
and copy number variation (CNV) provide thousands of
variants per individual [1-6]. Most bioinformatic methods
for identifying genes potentially associated with specific
phenotypes [7-9] are not optimized for Mendelian traits
with complete or incomplete clinical penetrance, because
they lack the metrics for estimating the relatedness of genes
not belonging to the same biological function pathway, or
because they generate complex networks that are difficult
to interpret, resulting in low discovery rates for disease-
causing alleles in high-throughput studies [10].
The causal genes of a specific phenotype are generally
expected to be functionally close to each other [11-13].
Candidate genes are therefore picked from high-throughput
data on the basis of their biological proximity to core
genes — genes already known to be responsible for the
phenotype. We recently developed a novel approach,
the “human gene connectome” (HGC). The HGC con-
sists of a method and database describing the set of in
silico-predicted biologically plausible routes and dis-
tances between all pairs of human genes. We used this
method to generate a “gene-specific connectome” for
each human gene, making it possible to rank all human
genes in terms of their biological proximity to a core
gene of interest. We have demonstrated that the HGC
is an effective approach for identifying Mendelian
disease-causing genes in high-throughput genetic data,
by the ranking of genes according to their biological
proximity to core genes known to be associated with
the phenotype of interest, as demonstrated by a case
study of herpes simplex encephalitis (HSE) and TLR3
pathway genes [10].
We present here the human gene connectome server
(HGCS): a novel, effective and easy-to-use interactive
online interface through which users can submit any
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gene list generated by high-throughput techniques (or
specific candidate genes of interest) for automatic
ranking in terms of biological distance and connectiv-
ity p-value to the known core genes of the phenotype
of interest, and the predicted route between the genes
of interest. The HGCS is based on the HGC-derived
concept of biological distance between gene pairs (that
are either directly or indirectly connected), and pro-
vides, for the first time, an opportunity for investiga-
tors of all backgrounds to prioritize independently lists
of genes of any size, according to their biological dis-
tance to core genes. We also provide a new database of
14,129 human gene-specific connectomes. We demon-
strate the power of the HGCS for prioritizing candi-
date genes, with whole-exome sequencing (WES) data
from 16 patients with HSE [14], Mendelian susceptibil-
ity to mycobacterial disease (MSMD) [15], or invasive
pneumococcal disease (IPD) [16]. We compare HGCS
with state-of-the-art methods.
Implementation
Generation of the HGC and of all human gene-specific
connectomes
We extracted data for all direct human protein-protein
physical interactions from the updated String version
9.05 (328,391 direct protein-protein binding interactions
in the current version, versus 146,566 in the previous
version, and a higher level of accuracy) [9] and inverted
the interaction confidence scores to obtain direct bio-
logical distances, which we used to create a weighted
graph of all available human genes. We applied a short-
est distance algorithm to find the biological distance and
route between all pairs of human genes, to generate the full
HGC, with the Python NetworkX package for complex
network analysis [17]. We then generated a gene-specific
connectome, by ranking all human genes according to
their HGC-predicted biological distance to a core gene.
We repeated the process for all human genes (See Itan,
et al., 2013 for a comprehensive description of the method-
ology). The human gene-specific connectomes are available
for use and can be downloaded from: http://lab.rockefeller.
edu/casanova/HGC.
Database and online server implementation
The full HGC and gene annotation data are stored on a
server, as indexed tables in a MySQL database. All hu-
man gene-specific connectomes were converted into a
MySQL table. The gene aliases and annotations were
compiled from Ensembl BioMart [18,19]. The main code
for ranking and annotations was written in PHP, so that
it could be run directly from the server. The program
uses mysqli_query() commands to access the database
and generate queries. The program is designed to maximize
gene discovery, by automatically detecting gene aliases if the
input is not the conventional gene name, and adding the full
gene name (e.g. Toll-like receptor 3 for TLR3) and alterna-
tive aliases.
Computing resources and programming languages
We generated the new HGC and all derived human
gene-specific connectomes with a Mac Pro computer
with a 12-core Intel CPU and 96 GB RAM. The initial
data filtering and text mining of the String database were
performed with the Perl programming language. The
HGC, gene-specific connectomes and simulations were
generated with the Python programming language. The
HGCS is hosted on The Rockefeller University LAMP
shared server, with a VMware instance of 4 GB.
Results
The human gene connectome server (HGCS)
The HGCS is a gene prioritization and connectivity on-
line interface based on biological distance, which allows
users to generate queries about any set of core and tar-
get genes. This system can be used for the rapid predic-
tion of the biological distance and connection route
between any two given genes of interest, and for the ef-
fective prioritization of any number of genes generated
by high-throughput methods, on the basis of their bio-
logical distance to core genes associated with the human
trait of interest or, alternatively, on the basis of p-value
or best reciprocal p-value (BRP, the smallest of the mu-
tual p-values between the core and target genes ac-
counting for central and isolated genes). A schematic
representation of the HGCS generation workflow is
shown in Figure 1. The output can be sorted by proximity
to any of the core genes provided, or internally separated
by core gene. Figure 2 shows screenshots of the HGCS on-
line platform, demonstrating the ranking of 284 genes from
WES data for an HSE patient, using TLR3 as the core gene.
The true HSE-causing gene for this patient, TICAM1
(TRIF), was ranked #1 among the 284 genes. The human
gene connectome server is available from: http://lab.rocke-
feller.edu/casanova/HGC.
Assessment of the performance of the HGCS
We assessed the power of the HGCS to detect Mendel-
ian disease-causing mutations from the WES data of 16
patients with severe Mendelian diseases: 7 patients with
HSE, 7 patients with MSMD and 2 patients with IPD.
The genes with disease-causing mutations in the HSE
patients were shown experimentally to be TICAM1
(TRIF, in two patients), TRAF3, TBK1 (in two patients),
and UNC93B1 (in two patients) [20-23]. The genes with
disease-causing mutations in the MSMD patients were
shown experimentally to be IFNGR2 (in two patients),
ISG15, STAT1, IL12RB1 (in two patients each), and
IL12B [24-28]. RBCK1 was identified as the gene with
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Figure 1 Schematic representation of the generation, data structure and workflow of the HGCS. (1) Extraction of all human direct protein-protein
binding interactions and the corresponding confidence scores from String. (2) Inversion of confidence scores to give direct biological distance metrics and
generation of a genome-wide human weighted network. (3) Generation, for each human gene, of a gene-specific connectome — the set of all other
human genes ranked according to their biological proximity to the specific gene. (4) Generation of a MySQL table from all human gene-specific connectomes.
(5) Extraction, from Ensembl BioMart, of all human protein IDs, gene IDs, and their corresponding conventional and full names. (6,7) Generation of a MySQL
table of all alternative gene names for each human gene. (8,9) Establishment of the full set of query gene names by identifying missing genes
with alternative gene name aliases, extracting the target genes from the connectomes of the core genes. (10) Sorting of the target genes
according to user-defined metrics, by relatedness to any of the core genes, or separated by core gene. The screen output can then be
downloaded as a tab-separated text file.
A B
Figure 2 The HGCS interface. (A) The two boxes contain the list of genes to prioritize/analyze (which can be acquired from any high-throughput
experiment after the application of filters; alternatively, any user-defined list of candidate genes can be used), and the core genes (known to be
associated with the phenotype) for ranking purposes. A scroll box allows a choice of metrics for ranking (distance, p-value, or best reciprocal p-value),
and the user may choose whether to rank the results globally, or separately by core gene. (B) The output consists of a table of genes ranked with respect to
the core genes, which can be downloaded as a tab-separated text file. The information about the nature of connectivity between the core and target genes
provided includes HGC-predicted biological distance, ranking of the target gene in the connectome of the core gene, the ratio between biological distance
and the genome-wide median and mean biological distances to the core gene, the sphere of the target gene around the core gene, degrees of separation
between the genes, and the full gene name.
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disease-causing mutations in the IPD patients [16]. We
performed standard filtering for the variants: (i) exclud-
ing synonymous variations, (ii) keeping rare variations,
with a frequency <1% in the 1000 Genomes [29] and
NHLBI Exome Variant Server (http://evs.gs.washington.
edu/EVS/) databases, and (iii) accounting for sequencing
batch effects and highly mutated genes (which are less
likely to be morbid) by in-house filtering of variants
appearing in more than 0.6% of the patients in all dis-
ease cohorts other than for the specific disease tested
(0.6% being the most stringent criterion that does not
filter out the true disease-causing gene in all patients,
for which filtering allows the removal of false-positive
genes abundant in WES data because they are naturally
highly mutated or due to sequencing errors causing the
same false mutations to appear in various WES samples).
Filtering decreased the median number of variant
genes per patient to 301. We chose TLR3 as the core
gene for HSE, IFNG as the core gene for MSMD, and
IKBKG as the core gene for IPD, because these genes
have been experimentally validated as central genes in
the gene pathways associated with the pathogenesis of
these diseases [14-16]. We used the HGCS to rank all
gene variants for each patient according to biological
proximity to the core gene associated with the patient’s
disease. We then compared the performance, interface
and functions of the HGCS with those of two other
state-of-the-art methods: (i) FunCoup, using the MaxLink
interface, which ranks top interactors, and (ii) HumanNet,
which ranks by top subnetworks [7,8]. In both FunCoup
and HumanNet, we added the relevant core genes to the
analyses, and chose the first cluster/subnetwork contain-
ing the true disease gene.
The human gene-specific connectome database
We generated and made available 14,129 human gene-
specific connectomes, each containing the set of all hu-
man genes ranked by their biological proximity to the
specific core gene of interest. Each gene-specific connec-
tome contains the following data categories regarding
the nature of the connection between the core gene and
the target genes: HGC-predicted biological distance,
rank among all human genes according to distance to
the core gene, p-value for connectivity, BRP, the ratio be-
tween the core gene—target gene distance and the me-
dian distance between the core gene and all human
genes, the ratio between the core gene—target gene
distance and mean distance between the core gene
and all human genes, the sphere around the core
gene (simplified percentile metrics), the predicted
route (i.e. the genes between the core and target
genes), degrees of separation (the number of direct
connections between the core and target genes), and the
full name of the target gene. All human gene-specific
connectomes are available from: http://lab.rockefeller.edu/
casanova/HGC.
Comparison of the HGCS with state-of-the-art methods
We assessed the ability of the HGCS to prioritize candi-
date genes in high-throughput data, using WES data for
16 patients who suffered from herpes simplex encephal-
itis (HSE, core gene TLR3, Additional files 1, 2, 3, 4, 5, 6
and 7: Table S1-S7) [14], Mendelian susceptibility to
mycobacterial disease (MSMD, core gene IFNG, Additional
files 8, 9, 10, 11, 12, 13 and 14: Table S8-S14) [15], or inva-
sive pneumococcal disease (IPD, core gene IKBKG,
Additional files 15 and 16: Tables S15 and S16) [16]
due to single-gene inborn errors of immunity. There
was a median of 301 WES-filtered genes per patient.
Additional files 1, 2, 3, 4, 5, 6 and 7: Tables S1-S7 show
the prioritized WES genes for each HSE patient, to-
gether with the connectivity between these genes and
TLR3 predicted by the HGCS. Additional files 8, 9, 10,
11, 12, 13 and 14: Tables S8-S14 show the prioritized
WES genes for each MSMD patient, and Additional
files 15 and 16: Tables S15 and S16 show the priori-
tized WES genes for each IPD patient. The true HSE-
causing genes (TICAM1 in two patients, TBK1 in two
patients, UNC93B1 in two patients and TRAF3 in a
single patient) were ranked #1 in all seven patients, in
terms of biological proximity to TLR3 among the
WES-filtered genes, P = 4.148E-17. The true MSMD-
causing genes (IFNGR2 in two patients, IL12RB1 in
two patients, ISG15, STAT1, and IL12B in single pa-
tients) were ranked #1 in five patients and #2 in two
patients, in terms of biological proximity to IFNG
among the WES-filtered genes, P = 1.243E-16. The true
IPD-causing gene (RBCK1 in two patients) was ranked
#15 in one patient and #18 in the second patient, in
terms of biological proximity to IKBKG among the
WES-filtered genes, P = 0.00185.
We compared the results obtained with those for
two other state-of-the-art methods (summarized in
Additional files 17: Table S17): (i) FunCoup: the true
disease gene was ranked 3 of 29, 7 of 29 and 1 of 29, in
3 of the 16 patients (for the detection of TICAM1 in
HSE and ISG15 and STAT1 in MSMD, respectively;
the true disease-causing gene was not ranked in the
remaining nine patients); (ii) HumanNet (allowing the
analysis of a maximum of 250 genes at a time, rather
than being core gene-centered): the true disease-
causing gene was ranked between #5 and #38 of 43 to
137 clusters in 12 patients, and was not ranked in the
remaining four patients. FunCoup and HumanNet cannot
rank genes relative to a core gene, and the prediction
therefore relates to a significant subnetwork containing
the true disease-causing gene. Predictions also involve
manual browsing of the output, making these methods
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less feasible for situations in which ranking on the basis of
several core genes is desired.
The HGCS differs from the FunCoup and HumanNet
interfaces in several major ways. FunCoup is based on
direct interactors or highly connected networks, and is
therefore particularly powerful for predicting closely re-
lated genes. By contrast, HumanNet was designed for
the discovery of new genes in a pathway, and is therefore
more suitable for more distantly related genes. Human-
Net provided results for 12 of the 16 patients (versus
only 3 patients for FunCoup and all 16 patients for the
HGCS). Neither FunCoup nor HumanNet is gene-
centric. These methods are therefore unable to rank a
list of genes according to their biological proximity to a
set of genes of interest, and they provide no information
about the route connecting human genes of interest.
Additional files 17: Table S17 shows comparisons of the
performances of the HGCS, FunCoup and HumanNet
interfaces for the detection of disease-causing genes
from WES data. In summary, for the 16 Mendelian
disease-causing genes for the patients whose WES data
were studied here, the HGCS outperformed FunCoup in
15 of the 16 tests, and outperformed HumanNet in 14 of
the 16 tests.
One of the major aims in studies of Mendelian dis-
eases is to identify, at the single-patient level, a single
gene associated with the disease. In this respect, the
HGCS is more effective than FunCoup and HumanNet,
because it is the only interface that ranks all candidate
genes on the basis of their relationship to the given core
gene. The other interfaces involve a binary yes/no indi-
cation of relatedness to core genes, making it difficult to
differentiate between the genes related to the core gene
and to identify the specific disease-causing gene. Fun-
Coup and HumanNet are conceptually easier to apply in
polygenic/complex genetic studies, as the input for these
two interfaces is the full set of candidate genes and there
is no need to supply a core gene, and they provide sub-
networks that can be inferred to be related to the
disease.
Discussion and conclusions
We present here the HGCS — the first online platform
for prioritizing any number of genes on the basis of their
biological distance to any number of core genes and the
relationships between them. We are making available an
updated database of all human gene-specific connec-
tomes. We demonstrate the high performance of the
HGCS for high-throughput Mendelian and monogenic
studies. We propose an effective method for the use of
the HGCS to detect new disease-related genes, based on
the collation of central core genes known to be associ-
ated with the disease and their use to rank the candidate
genes by distance, P-value, or BRP (a less stringent
scoring, better reflecting the mutual connection when
the target gene is less central, but probably associated
with a higher false-positive rate). We suggest that P-
values or BRP could be used to rank lists of gene candi-
dates, rather than for drawing statistical/translational
conclusions that a gene is relevant to the phenotype on
the basis of statistical significance.
The HGCS performance is dependent upon a reliable
selection of core gene(s) associated with the phenotype.
This task is straightforward when certain causal genes
have already been identified in previous studies. How-
ever, in the absence of experimentally validated core
genes, the identification of candidate core genes is not
trivial. In such cases, we suggest using core genes of the
phenotypes most similar to the phenotype of interest, or
alternatively using other state-of-the-art approaches de-
scribed in this work, such as FunCoup and HumanNet.
The centrality/connectivity of the selected core genes
also influences the HGCS performance, which, in the
case of IPD, was decreased with IKBKG as a core gene
(although still highly significant). We suggest that since
IKBKG is a highly central/connected gene with a high
number of strongly associated genes, it is less effective
for differentiating the highly ranked gene candidates. In
such cases we propose ranking by additional core genes,
if available.
The HGCS has several unique features not found in
other state-of-the-art methodologies, including the pre-
diction of meaningful indirect interactions, the provision
of a biological distance and route between any two given
human genes of interest, and its gene-centric nature,
making it particularly useful in diseases or pathways for
which associated genes have already been detected and for
which the task is detecting and describing new disease- or
pathway-associated genes. We anticipate that the rigorous
use of the HGCS and the novel concept of biological dis-
tance will significantly increase the rate of discovery of
new genotype-phenotype causal relationships.
Availability and requirements
Project name: the human gene connectome server (HGCS)
Project home page: http://hgc.rockefeller.edu/
Operating system(s): platform independent.
Programming languages: Python, MySQL, PHP.
License: free to noncommercial users.
Additional files
Additional file 1: Table S1. HGCS-prioritized genes for the first HSE
patient for whom TICAM1 (TRIF) was the experimentally validated
disease-causing gene. This table shows all filtered gene variants identified
by WES for the patient, ranked according to their HGC-predicted biological
proximity to TLR3. The true HSE-causing gene, TICAM1 (TRIF), in this patient
was ranked 1st.
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Additional file 2: Table S2. HGCS-prioritized genes for the second HSE
patient for whom TICAM1 (TRIF) was the experimentally validated
disease-causing gene. This table shows all filtered gene variants identified
by WES for the patient, ranked according to their HGC-predicted biological
proximity to TLR3. The true HSE-causing gene, TICAM1 (TRIF), in this patient
was ranked 1st.
Additional file 3: Table S3. HGCS-prioritized genes for the first HSE
patient for whom TBK1 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to HGC-predicted biological proximity to TLR3.
The true HSE-causing gene, TBK1, was ranked 1st.
Additional file 4: Table S4. HGCS-prioritized genes for the second HSE
patient for whom TBK1 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to their HGC-predicted biological proximity to
TLR3. The true HSE-causing gene, TBK1, was ranked 1st.
Additional file 5: Table S5. HGCS-prioritized genes from an HSE
patient for whom TRAF3 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to their HGC-predicted biological proximity
to TLR3. The true HSE-causing gene, TRAF3, was ranked 1st.
Additional file 6: Table S6. HGCS-prioritized genes for the first HSE
patient for whom UNC93B1 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to HGC-predicted biological proximity to
TLR3. The true HSE-causing gene, UNC93B1, was ranked 1st.
Additional file 7: Table S7. HGCS-prioritized genes for the second HSE
patient for whom UNC93B1 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to HGC-predicted biological proximity to
TLR3. The true HSE-causing gene, UNC93B1, was ranked 1st.
Additional file 8: Table S8. HGCS-prioritized genes from the first
MSMD patient for whom IFNGR2 was the experimentally validated
disease-causing gene. This table shows all filtered gene variants identified
by WES for the patient, ranked according to their HGC-predicted biological
proximity to IFNG. The true MSMD-causing gene, IFNGR2, was ranked 1st.
Additional file 9: Table S9. HGCS-prioritized genes from the second
MSMD patient for whom IFNGR2 was the experimentally validated
disease-causing gene. This table shows all filtered gene variants identified
by WES for the patient, ranked according to their HGC-predicted biological
proximity to IFNG. The true MSMD-causing gene, IFNGR2, was ranked 1st.
Additional file 10: Table S10. HGCS-prioritized genes from an MSMD
patient for whom ISG15 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to their HGC-predicted biological proximity to
IFNG. The true MSMD-causing gene, ISG15, was ranked 2nd.
Additional file 11: Table S11. HGCS-prioritized genes from an MSMD
patient for whom STAT1 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to their HGC-predicted biological proximity to
IFNG. The true MSMD-causing gene, STAT1, was ranked 1st.
Additional file 12: Table S12. HGCS-prioritized genes from the first
MSMD patient for whom IL12RB1 was the experimentally validated
disease-causing gene. This table shows all filtered gene variants identified
by WES for the patient, ranked according to their HGC-predicted biological
proximity to IFNG. The true MSMD-causing gene, IL12RB1, was ranked 1st.
Additional file 13: Table S13. HGCS-prioritized genes from the second
MSMD patient for whom IL12RB1 was the experimentally validated
disease-causing gene. This table shows all filtered gene variants identified
by WES for the patient, ranked according to their HGC-predicted biological
proximity to IFNG. The true MSMD-causing gene, IL12RB1, was ranked 2nd.
Additional file 14: Table S14. HGCS-prioritized genes from an MSMD
patient for whom IL12B was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to their HGC-predicted biological proximity to
IFNG. The true MSMD-causing gene, IL12B, was ranked 1st.
Additional file 15: Table S15. HGCS-prioritized genes from the first IPD
patient for whom RBCK1 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to their HGC-predicted biological proximity
to IKBKG. The true IPD-causing gene, RBCK1, was ranked 15th.
Additional file 16: Table S16. HGCS-prioritized genes from the second
IPD patient for whom RBCK1 was the experimentally validated disease-causing
gene. This table shows all filtered gene variants identified by WES for the
patient, ranked according to their HGC-predicted biological proximity
to IKBKG. The true IPD-causing gene, RBCK1, was ranked 18th.
Additional file 17: Table S17. Comparison of the performances of the
HGCS and other state-of-the-art methods for the detection of disease
genes in WES data. This table shows rankings obtained with the HGCS,
HumanNet and FunCoup (for a median of 301 genes per patient) for the
true HSE, MSMD and IPD disease-causing genes in the exomes of 16
patients.
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